Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950233 · ClinicalTrials.gov registry record · Phase 3
Preventing pAIn With NMDA Antagonists - Steroids in Thoracoscopic lObectomy Procedures (PAIN-STOP) Pilot Trial
A Phase 3 study, sponsored by Population Health Research Institute.
- Terminated
- Registry status
- Phase 3
- Development phase
- 27
- Enrollment target
NCT02950233 is a Phase 3 study that was terminated before completion, run by Population Health Research Institute. The registered enrollment target is 27 participants.
The verdict
NCT02950233, a Phase 3 study, was terminated before completion, sponsored by Population Health Research Institute.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 27 participants
- Enrollment target
Study Summary
The objective of the PAIN-STOP trial is to assess the feasibility of a larger randomized controlled trial (RCT) evaluating NMDA antagonists and IV steroids, as compared to placebo, in decreasing the chances of clinically significant persistent post-surgical pain (PPSP) after video assisted thoracoscopic surgeries (VATS). This is a multi-centre randomized, controlled clinical trial with a 2 x 2 factorial design. The pilot phase of the trial will recruit 48 patients and follow them for 3 months. Patients will be randomized to one of four groups: 1) NMDA active + Steroid placebo; 2) Steroid active + NMDA placebo; 3) NMDA active + Steroid active; 4) NMDA placebo + Steroid placebo.
Interventions
- DRUG NMDA active
- DRUG Steroid active
- DRUG NMDA placebo
- DRUG Steroid placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-05-04 |
| Est. Completion | 2019-03-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950233
The ClinicalTrials.gov registry entry for NCT02950233 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Health Research Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which NMDA active is the first listed.
NCT02950233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950233 about?
NCT02950233 is a clinical study titled "Preventing pAIn With NMDA Antagonists - Steroids in Thoracoscopic lObectomy Procedures (PAIN-STOP) Pilot Trial". The objective of the PAIN-STOP trial is to assess the feasibility of a larger randomized controlled trial (RCT) evaluating NMDA antagonists and IV steroids, as compared to placebo, in decreasing the chances of clinically significant persistent post-surgical pain (PPSP) after video assisted thoracosc...
What is the current status of trial NCT02950233?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 27 participants. The study started on 2017-05-04. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT02950233?
The interventions under investigation include: NMDA active (DRUG), Steroid active (DRUG), NMDA placebo (DRUG), Steroid placebo (DRUG).
Who is sponsoring clinical trial NCT02950233?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.